Virokines in the pathogenesis of cancer: Focus on human herpesvirus 8

Annals of the New York Academy of Sciences

Volumn 1028, Issue , 2004, Pages 329-339

  Klouche, Mariam ^a,e   Carruba, Giuseppe ^b   Castagnetta, Luigi ^b,c   Rose John, Stefan ^d  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF PALERMO   (Italy)

^c Ospedale Oncologico M Ascoli   (Italy)

^d UNIVERSITY OF KIEL   (Germany)

^e Bremer Zentrum fur Laboratoriumsmedizin   (Germany)

Author keywords

Cancer; Interleukin 6; Signal transduction; Viroceptor; Virokine

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1; MACROPHAGE INFLAMMATORY PROTEIN 2;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ANTIGEN RECOGNITION; APOPTOSIS; AUTOCRINE EFFECT; CARCINOGENESIS; CELL COMMUNICATION; CELL GROWTH; CELL SURVIVAL; CONFERENCE PAPER; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MALIGNANT TRANSFORMATION; MITOGENESIS; PARACRINE SIGNALING; PLEURA EFFUSION; REGULATOR GENE; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; VIRUS GENOME; VIRUS REPLICATION;

DNA VIRUSES; HERPESVIRIDAE; HERPESVIRUS 8; HUMAN HERPESVIRUS 8;

EID: 14944366493     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (56)

1. MCFADDEN, G. & P.M. MURPHY. 2000. Host-related immunomodulators encoded by poxviruses and herpesviruses. Curr. Opin. Microbiol. 3: 371-378.
2. HAIG, D.M. 2001. Subversion and piracy: DNA viruses and immune evasion. Res. Vet. Sci. 70: 205-219.
3. FLAITZ, C.M. & M.J. HICKS. 1998. Molecular piracy: the viral link to carcinogenesis. Oral Oncol. 34: 448-453.
4. CHANG, Y., E. CESARMAN, M.S. PESSIN, et al. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266: 1865-1869.
5. AOKI, Y. & G. TOSATO. 2003. Pathogenesis and manifestations of human herpesvirus-8-associated disorders. Semin. Hematol. 40: 143-153.
6. DUPON, M., B. MASQUELIER, C. CAZORLA, et al. 1997. Acquired immunodeficiency syndrome-associated Kaposi's sarcoma and human herpesvirus 8 DNA detection in serial peripheral blood mononuclear cell samples. Res. Virol. 148: 417-425.
7. MOORE, P.S., C. BOSHOFF, R.A. WEISS, et al. 1996. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 274: 1739-1744.
8. BOSHOFF, C., Y. ENDO, P.D. COLLINS, et al. 1997. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science 278: 290-294.
9. ENSOLI, B. & M.C. SIRIANNI. 1998. Kaposi's sarcoma pathogenesis: a link between immunology and tumor biology. Crit. Rev. Oncog. 9: 107-124.
10. BLASIG, C., C. ZIETZ, B. HAAR, et al. 1997. Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8. J. Virol. 71: 7963-7968.
11. GOEDERT, J.J., F. VITALE, C. LAURIA, et al. 2002. Classical Kaposi's Sarcoma Working Group. Risk factors for classical Kaposi's sarcoma. J. Natl. Cancer Inst. 94: 1712-1718.
12. ISCOVICH, J., P. BOFFETTA & R. WINKELMANN. 1998. Classic Kaposi's sarcoma in Jews living in Israel, 1961-1989: a population-based incidence study. AIDS 12: 2067-2072.
13. GOEDERT, J.J., T.R. COTE & P. VIRGO. 1998. Spectrum of AIDS-associated malignant disorders. Lancet 351: 1833-1839.
14. VITALE, F., D.V. BRIFFA, D. WHITBY, et al. 2001. Kaposi's sarcoma herpes virus and Kaposi's sarcoma in the elderly populations of 3 Mediterranean islands. Int. J. Cancer 91: 588-591.
15. CATTANI, P., F. CERIMELE, D. PORTA, et al. 2003. Age-specific seroprevalence of human herpesvirus 8 in Mediterranean regions. Clin. Microbiol. Infect. 9: 274-279.
16. VITALE, F., E. VIVIANO, A.M. PERNA, et al. 2000. Serological and virological evidence of non-sexual transmission of human herpesvirus type 8 (HHV8). Epidemiol. Infect. 125: 671-675.
17. Russo, J.J., R.A. BOHENZKY, M.C CHIEN, et al. 1996. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. USA 93: 14862-14867.
18. GANEM, D. 1997. KSHV and Kaposi's sarcoma: the end of the beginning? Cell 91: 157-160.
19. MOSES, A.V., K.N. FISH, R. RUHL, et al. 1999. Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8. J. Virol. 73: 6892-6902.
20. AOKI, Y., E.S. JAFFE, Y. CHANG, et al. 1999. Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood 93: 4034-4043.
21. BAIS, C., B. SANTOMASSO, O. COSO, et al. 1998. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 391: 86-89.
22. GAO, S.J., C. BOSHOFF, S. JAYACHANDRA, et al. 1997. KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene 15: 1979-1985.
23. MURALIDHAR, S., G. VEYTSMANN, B. CHANDRAN, et al. 2000. Characterization of the human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) oncogene, kaposin (ORF K12). J. Clin. Virol. 16: 203-213.
24. GRUNDHOFF, A. & D. GANEM. 2004. Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. J. Clin. Invest. 113: 124-136.
25. NEIPEL, F., J.C. ALBRECHT, A. ENSSER, et al. 1997. Human herpesvirus 8 encodes a homolog of interleukin-6. J. Virol. 71: 839-842.
26. NICHOLAS, J., V.R. RUVOLO, W.H. BURNS, et al. 1997. Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat. Med. 3: 287-292.
27. KLOUCHE, M., N. BROCKMEYER, C. KNABBE, et al. 2002. Human herpesvirus 8-derived viral IL-6 induces PTX3 expression in Kaposi's sarcoma cells. AIDS 16:F9-18.
28. BURGER, R., F. NEIPEL, B. FLECKENSTEIN, et al. 1998. Human herpesvirus type 8 interleukin-6 homologue is functionally active on human myeloma cells. Blood 91: 1858-1863.
29. STASKUS, K.A., R. SUN, G. MILLER, et al. 1999. Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. J. Virol. 73: 4181-4187.
30. PARRAVINCI, C., M. CORBELLINO, M. PAULLI, et al. 1997. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. Am. J. Pathol. 151: 1517-1522.
31. PARRAVICINI, C., B. CHANDRAN, M. CORBELLINO, et al. 2000. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Am. J. Pathol. 156: 743-749.
32. LUPPI, M., P. BAROZZI, A. MAIORANA, et al. 1999. Expression of cell-homologous genes of human herpesvirus-8 in human immunodeficiency virus-negative lymphoproliferative diseases. Blood 94: 2931-2933.
33. HOWARD, O.M. & W.L. FARRAR. 1998. The chemokine kidnapping receptor of HHV8. J. Clin. Invest. 102: 1467-1468.
34. CHEN, S., K.B. BACON, L. LI, et al. 1998. In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II. J. Exp. Med. 188: 193-198.
35. ARVANITAKIS, L., E. GERAS-RAAKA, A. VARMA, et al. 1997. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 385: 347-350.
36. CHOI, J., R.E. MEANS, B. DAMANIA, et al. 2001. Molecular piracy of Kaposi's sarcoma associated herpesvirus. Cytokine Growth Factor Rev. 12: 245-257.
37. YANG, T.Y., S.C. CHEN, M.W. LEACH, et al. 2000. Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. J. Exp. Med. 191: 445-454.
38. TAGA, T. & T. KISHIMOTO. 1997 Gp130 and the interleukin-6 family of cytokines. Annu. Rev. Immunol. 15: 797-819.
39. GRÖTZINGER, J., T. KERNEBECK, K.J. KALLEN, et al. 1999. IL-6 type cytokine receptor complexes: hexamer, tetramer or both? Biol. Chem. 380: 803-813.
40. MOLDEN, J., Y. CHANG, Y. YOU, et al. 1997. A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J. Biol. Chem. 272: 19625-19631.
41. MÜLLBERG, J., T. GEIB, T. JOSTOCK, et al. 2000. IL-6 receptor independent stimulation of human gp130 by viral IL-6. J. Immunol. 164: 4672-4677.
42. HOISCHEN, S.H., P. VOLLMER, P. MÄRZ, et al. 2000. Human herpes virus 8 interleukin-6 homologue triggers gp130 on neuronal and hematopoietic cells. Eur. J. Biochem. 267: 3604-3612.
43. MURAKAMI-MORI, K., T. TAGA, T. KISHIMOTO, et al. 1996. The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth. Int. Immunol. 8: 595-602.
44. CHOW, D., X. HE, A.L. SNOW, et al. 2001. Structure of an extracellular gp130 cytokine receptor signaling complex. Science 291: 2150-2155.
45. SCHWANTNER, A., A.J. DINGLEY, S. OZBEK, et al. 2004. Direct determination of the interleukin-6 binding epitope of the interleukin-6 receptor by NMR spectroscopy. J. Biol. Chem. 279: 571-576.
46. ROSE-JOHN, S. & P.C. HEINRICH. 1994. Soluble receptors for cytokines and growth factors: generation and biological function. Biochem. J. 300: 281-290.
47. KLOUCHE, M., S. BHAKDI, M. HEMMES, et al. 1999. Novel path to activation of vascular smooth muscle cells: up-regulation of gp130 creates an autocrine activation loop by IL-6 and its soluble receptor. J. Immunol. 163: 4583-4589.
48. KLOUCHE, M., S. ROSE-JOHN, W. SCHMIEDT, et al. 2000. Enzymatically degraded, non-oxidized LDL induces human vascular smooth muscle cell activation, foam cell transformation, and proliferation. Circulation 101: 1799-1805.
49. LI, M., H. LEE, D.W. YOON, et al. 1997. Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin. J. Virol. 71: 1984-1991.
50. CANNELL, E. & S. MITTNACHT. 1999. Viral encoded cyclins. Semin. Cancer Biol. 9: 221-229.
51. SWANTON, C., D.J. MANN, B. FLECKENSTEIN, et al. 1997. Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins. Nature 390: 184-187.
52. CHENG, E.H., J. NICHOLAS, D.S. BELLOWS, et al. 1997. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc. Natl. Acad. Sci. USA 94: 690-694.
53. DJERBI, M., V. SCREPANTI, A.I. CATRINA, et al. 1999. The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors. J. Exp. Med. 190: 1025-1032.
54. COSCOY, L., D.J. SANCHEZ & D. GANEM. 2001. A novel class of herpesvirus-encoded membrane-bound E3 ubiquitin ligases regulates endocytosis of proteins involved in immune recognition. J. Cell Biol. 155: 1265-1273.
55. LEE, B.S., X. ALVAREZ, S. ISHIDO, et al. 2000. Inhibition of intracellular transport of B cell antigen receptor complexes by Kaposi's sarcoma-associated herpesvirus K1. J. Exp. Med. 192: 11-21.
56. ISHIDO, S., J.K. CHOI, B.S. LEE, et al. 2000. Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein. Immunity 13: 365-374.